SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kos Pharmaceuticals, Inc (KOSP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom D who wrote (3)8/10/1997 10:14:00 AM
From: BMB   of 118
 
Hi TDD & all: Aug.11th issue of (IBD)Investors Business Daily's New America Section has a very detailed and possitve report on KOSP.In general, article in it leads to a significant possitive reaction in stock price for about one or two days if it did not run up prior to the report.(Monday issue of IBD comes on Saturday). By looking at the chart it looks that there may be a gap up at the open and may even hit a new high(~$42)intraday! But the Profit taking will determine the closing price! On Friday it was down only $0.25 and has been trading around $38 for the last 8 days ever since it hit a new high of $40.75 (intraday) on 7/29/97. Chart pattern is very possite with an uptrend long term! IBD article indicates that "KOSP plans to file marketing clearence in Europe soon and is looking for a marketing parterner there. KOSP is developing atleast eight other drugs and working on a combination drug of niacin and a major statin. This drug if approved, could be another block buster" The very bullish analyst covering KOSP and quoted in IBD article is Leonard Yaffe of Montgomery Securities.. ...BMB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext